Benefit Street Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-157,670
Closed -$3.49M 23
2019
Q3
$3.49M Buy
157,670
+11,500
+8% +$245K 0.87% 17
2019
Q2
$3.02M Sell
146,170
-59,497
-29% -$1.37M 0.28% 23
2019
Q1
$5.93M Buy
205,667
+57,216
+39% +$1.41M 0.51% 13
2018
Q4
$2.54M Buy
+148,451
New +$3.59M 0.37% 19
2018
Q1
Sell
-602,058
Closed -$9.13M 38
2017
Q4
$9.13M Buy
602,058
+283,479
+89% +$3.99M 0.63% 10
2017
Q3
$5.23M Buy
+318,579
New +$5.4M 3.01% 8
2017
Q2
Sell
-113,000
Closed -$2M 29
2017
Q1
$2M Sell
113,000
-1,493
-1% -$27.7K 1.34% 16
2016
Q4
$1.7M Buy
+114,493
New +$2.05M 1.3% 16

Other funds holding THC

Benefit Street Partners's THC Position: Q4 2019 in Review

Benefit Street Partners sold out of Tenet Healthcare (THC) in Q4 2019, closing a stake of 157,670 shares — an estimated $3.49M sold.

Benefit Street Partners first reported a position in THC in Q4 2016 and held it in 8 quarters. The position peaked at $9.13M in Q4 2017. 265 funds tracked by Wall St. Rank hold THC as of Q4 2019.

  • Benefit Street Partners reported no remaining Tenet Healthcare position as of Q4 2019 after selling out during the quarter.
  • Benefit Street Partners sold 157,670 Tenet Healthcare shares in Q4 2019, an estimated $3.49M.
  • Benefit Street Partners first reported a position in Tenet Healthcare in Q4 2016 and held it in 8 quarters.
  • Benefit Street Partners's Tenet Healthcare position peaked at $9.13M in Q4 2017.
  • 265 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2019.

Based on Benefit Street Partners's 13F filing for Q4 2019, filed 13 Feb 2020.